Facility news from BioMarin, Lonza and Neptune Technologies, plus plans to boost biomanufacturing capacity in the developing world and new …
Akzo Nobel has been taken to task by the US FDA for manufacturing standards at one of its active pharmaceutical …

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …

Germany’s new pricing committee has said that AstraZeneca’s Brilique is a cost effective treatment for patients with a certain heart …

The former head of the European Medicines Agency Thomas Lonngren set up his own consultancy business to advise pharma whilst …

Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …
Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …
During the recent London Vet Show the autoclave featured on the Southwest Medical stand R30 certainly proved a popular visitor …
York University is shortly taking delivery of a number of priorclaves for use in the Biology Department’s Teaching Laboratories and …

Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million. The unit has been sold to …

The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf. The European regulator’s Committee for Medicinal …

Health Secretary Andrew Lansley was on the end of a verbal battering by GP and journalist Dr Phil Hammond on …
Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …

Chandler Chicco Companies is to acquire German healthcare communication firms, Haas & Health Partner Public Relations and SanCom Creative Communication …

Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …
Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …

AstraZeneca has appointed Lisa Anson as its new president for the firm’s UK marketing company, effective 1 January 2012. Anson …

Brand managers invest a huge amount of time every year preparing brand plans – but often without really knowing what …

Novartis has officially started production at a first-of-its kind cell-based manufacturing facility for influenza vaccines in North Carolina, US. The …
Eli Lilly has filed a planning application to build a new 23,000 sq. m. biologics facility at its manufacturing site …